Skip to main content
Top
Published in: Virology Journal 1/2020

Open Access 01-12-2020 | Uveitis | Case Report

Chronic active Epstein–Barr virus infection manifesting as coronary artery aneurysm and uveitis

Authors: Haijuan Xiao, Bing Hu, Rongmu Luo, Huili Hu, Junmei Zhang, Weiying Kuang, Rui Zhang, Li Li, Gang Liu

Published in: Virology Journal | Issue 1/2020

Login to get access

Abstract

Background

Chronic active Epstein–Barr virus (CAEBV) infection is a type of lymphoproliferative disorder characterized by chronic or recurrent infectious mononucleosis (IM)-like symptoms, which can have less-frequent clinical presentations. The prognosis of CAEBV is poor, and hematopoietic stem cell transplantation (HSCT) has been shown to be the only potentially effective treatment. In this article, we present a special CAEBV case of a patient who had no typical IM-like symptoms at the early stage, but manifested with severe and progressive coronary artery aneurysm (CAA), abdominal aortic lesions, and severe uveitis. These manifestations were uncommon features and could only be blocked by HSCT.

Case presentation

A 4-year-old girl with no special medical history complained of decreased vision for 10 months and cough after physical activities for three months. The blurred vision grew rapidly worse within one month, until only light perception remained. She was diagnosed with uveitis and cataract, and received prednisone and ciclosporin A treatment. However, her vision did not improve. Physical examination showed slight hepatosplenomegaly. Ultrasonic cardiogram showed bilateral CAA (5.0 mm and 5.7 mm for inner diameters), and abdominal CT scan revealed a thickened aortic wall, as well as stenosis and dilation of the segmental abdominal aorta. Other significant findings were increased EBV-DNA (3.29 × 104 copies/mL) from peripheral blood, positive EBV antibodies (EBV-CA-IgG, EBV-EA-IgA, and EBV-NA-IgG), and positive EBV-encoded small RNAs found by bone marrow biopsy. Based on her clinical manifestations and evidence for EBV infection, we diagnosed CAEBV. She received allogeneic HSCT, and the cataract operation was performed after HSCT. EBV-DNA could not be detected in peripheral blood after HSCT. Her CAAs did not progress, and uveitis was well controlled. Her vision recovered gradually over the 3 years after HSCT.

Conclusions

We present a rare CAEBV case of a patient who suffered from uncommon and severe cardiovascular and ocular involvement that was relieved by HSCT. Therefore, early recognition and diagnosis of CAEBV are of vital importance to improve its prognosis. In summary, this atypical CAEBV case could help us recognize similar cases more easily, make the right diagnosis as early as possible, and deliver proper and timely treatment.
Literature
1.
go back to reference Fujiwara S, Kimura H, Imadome K, Arai A, Kodama E, Morio T, Shimizu N, Wakiguchi H. Current research on chronic active Epstein–Barr virus infection in Japan. Pediatr Int. 2014;56(2):159–66.CrossRef Fujiwara S, Kimura H, Imadome K, Arai A, Kodama E, Morio T, Shimizu N, Wakiguchi H. Current research on chronic active Epstein–Barr virus infection in Japan. Pediatr Int. 2014;56(2):159–66.CrossRef
2.
go back to reference Kim HJ, Ko YH, Kim JE, Lee SS, Lee H, Park G, Paik JH, Cha HJ, Choi YD, Han JH, et al. Epstein–Barr virus-associated lymphoproliferative disorders: review and update on 2016 WHO classification. J Pathol Transl Med. 2017;51(4):352–8.CrossRef Kim HJ, Ko YH, Kim JE, Lee SS, Lee H, Park G, Paik JH, Cha HJ, Choi YD, Han JH, et al. Epstein–Barr virus-associated lymphoproliferative disorders: review and update on 2016 WHO classification. J Pathol Transl Med. 2017;51(4):352–8.CrossRef
3.
go back to reference Kimura H. Pathogenesis of chronic active Epstein–Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16(4):251–61.CrossRef Kimura H. Pathogenesis of chronic active Epstein–Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol. 2006;16(4):251–61.CrossRef
4.
go back to reference Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, Group CS. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58(4):209–17.CrossRef Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, Group CS. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58(4):209–17.CrossRef
5.
go back to reference Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, et al. Defective Epstein–Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404–13.CrossRef Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, et al. Defective Epstein–Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404–13.CrossRef
6.
7.
go back to reference Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64.CrossRef Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64.CrossRef
8.
go back to reference Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37(2):217–22.CrossRef Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37(2):217–22.CrossRef
9.
go back to reference Abou Sherif S, Ozden Tok O, Taskoylu O, Goktekin O, Kilic ID. Coronary artery aneurysms: a review of the epidemiology, pathophysiology, diagnosis, and treatment. Front Cardiovasc Med. 2017;4:24.CrossRef Abou Sherif S, Ozden Tok O, Taskoylu O, Goktekin O, Kilic ID. Coronary artery aneurysms: a review of the epidemiology, pathophysiology, diagnosis, and treatment. Front Cardiovasc Med. 2017;4:24.CrossRef
10.
go back to reference Krishna U, Ajanaku D, Denniston AK, Gkika T. Uveitis: a sight-threatening disease which can impact all systems. Postgrad Med J. 2017;93(1106):766–73.CrossRef Krishna U, Ajanaku D, Denniston AK, Gkika T. Uveitis: a sight-threatening disease which can impact all systems. Postgrad Med J. 2017;93(1106):766–73.CrossRef
11.
go back to reference Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1–2.CrossRef Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1–2.CrossRef
12.
go back to reference Muneuchi J, Ohga S, Ishimura M, Ikeda K, Yamaguchi K, Nomura A, Takada H, Abe Y, Hara T. Cardiovascular complications associated with chronic active Epstein–Barr virus infection. Pediatr Cardiol. 2009;30(3):274–81.CrossRef Muneuchi J, Ohga S, Ishimura M, Ikeda K, Yamaguchi K, Nomura A, Takada H, Abe Y, Hara T. Cardiovascular complications associated with chronic active Epstein–Barr virus infection. Pediatr Cardiol. 2009;30(3):274–81.CrossRef
13.
go back to reference Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, et al. Prognostic factors for chronic active Epstein–Barr virus infection. J Infect Dis. 2003;187(4):527–33.CrossRef Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, et al. Prognostic factors for chronic active Epstein–Barr virus infection. J Infect Dis. 2003;187(4):527–33.CrossRef
14.
go back to reference Nakagawa A, Ito M, Iwaki T, Yatabe Y, Asai J, Hayashi K. Chronic active Epstein–Barr virus infection with giant coronary aneurysms. Am J Clin Pathol. 1996;105(6):733–6.CrossRef Nakagawa A, Ito M, Iwaki T, Yatabe Y, Asai J, Hayashi K. Chronic active Epstein–Barr virus infection with giant coronary aneurysms. Am J Clin Pathol. 1996;105(6):733–6.CrossRef
15.
go back to reference Fujiwara M, Shimozono H, Ono H, Fujita N, Nishimura S, Ueda K, Kaneko M. Polyclonal proliferation of lymphocytes containing the Epstein–Barr virus genome in a patient dying of myocarditis in chronic active Epstein–Barr virus infection. J Pediatr Hematol Oncol. 2003;25(1):85–8.CrossRef Fujiwara M, Shimozono H, Ono H, Fujita N, Nishimura S, Ueda K, Kaneko M. Polyclonal proliferation of lymphocytes containing the Epstein–Barr virus genome in a patient dying of myocarditis in chronic active Epstein–Barr virus infection. J Pediatr Hematol Oncol. 2003;25(1):85–8.CrossRef
16.
go back to reference Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol. 2008;130(3):335–43.CrossRef Antoniadis AP, Chatzizisis YS, Giannoglou GD. Pathogenetic mechanisms of coronary ectasia. Int J Cardiol. 2008;130(3):335–43.CrossRef
17.
go back to reference Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation. 2001;104(8):860–3.CrossRef Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation. 2001;104(8):860–3.CrossRef
18.
go back to reference Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr. 2000;159(6):424–9.CrossRef Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr. 2000;159(6):424–9.CrossRef
19.
go back to reference Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F. Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide. 2003;8(1):15–25.CrossRef Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F. Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide. 2003;8(1):15–25.CrossRef
20.
go back to reference Manginas A, Cokkinos DV. Coronary artery ectasias: imaging, functional assessment and clinical implications. Eur Heart J. 2006;27(9):1026–31.CrossRef Manginas A, Cokkinos DV. Coronary artery ectasias: imaging, functional assessment and clinical implications. Eur Heart J. 2006;27(9):1026–31.CrossRef
21.
go back to reference Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol. 2014;8:1891–911.PubMedPubMedCentral Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol. 2014;8:1891–911.PubMedPubMedCentral
22.
go back to reference Wong KW, D’Amico DJ, Hedges TR 3rd, Soong HK, Schooley RT, Kenyon KR. Ocular involvement associated with chronic Epstein–Barr virus disease. Arch Ophthalmol. 1987;105(6):788–92.CrossRef Wong KW, D’Amico DJ, Hedges TR 3rd, Soong HK, Schooley RT, Kenyon KR. Ocular involvement associated with chronic Epstein–Barr virus disease. Arch Ophthalmol. 1987;105(6):788–92.CrossRef
23.
go back to reference Morishima N, Miyakawa S, Akazawa Y, Takagi S. A Case of uveitis associated with chronic active Epstein–Barr virus infection. Ophthalmologica. 1996;210(3):186–8.CrossRef Morishima N, Miyakawa S, Akazawa Y, Takagi S. A Case of uveitis associated with chronic active Epstein–Barr virus infection. Ophthalmologica. 1996;210(3):186–8.CrossRef
24.
go back to reference Blum-Hareuveni T, Seguin-Greenstein S, Kramer M, Hareuveni G, Sharon Y, Friling R, Sharief L, Lightman S, Tomkins-Netzer O. Risk factors for the development of cataract in children with uveitis. Am J Ophthalmol. 2017;177:139–43.CrossRef Blum-Hareuveni T, Seguin-Greenstein S, Kramer M, Hareuveni G, Sharon Y, Friling R, Sharief L, Lightman S, Tomkins-Netzer O. Risk factors for the development of cataract in children with uveitis. Am J Ophthalmol. 2017;177:139–43.CrossRef
25.
go back to reference Nakagawa A, Ito M, Saga S. Fatal cytotoxic T-cell proliferation in chronic active Epstein–Barr virus infection in childhood. Am J Clin Pathol. 2002;117(2):283–90.CrossRef Nakagawa A, Ito M, Saga S. Fatal cytotoxic T-cell proliferation in chronic active Epstein–Barr virus infection in childhood. Am J Clin Pathol. 2002;117(2):283–90.CrossRef
26.
go back to reference Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, Nakano M. Detection of Epstein–Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein–Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr. 1993;123(1):90–2.CrossRef Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, Nakano M. Detection of Epstein–Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein–Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr. 1993;123(1):90–2.CrossRef
27.
go back to reference Fukuda Y, Momoi N, Akaihata M, Nagasawa K, Mitomo M, Aoyagi Y, Endoh K, Hosoya M. Pulmonary arterial hypertension associated with chronic active Epstein–Barr virus infection. Pediatr Int. 2015;57(4):731–4.CrossRef Fukuda Y, Momoi N, Akaihata M, Nagasawa K, Mitomo M, Aoyagi Y, Endoh K, Hosoya M. Pulmonary arterial hypertension associated with chronic active Epstein–Barr virus infection. Pediatr Int. 2015;57(4):731–4.CrossRef
28.
go back to reference Murakami K, Ohsawa M, Hu SX, Kanno H, Aozasa K, Nose M. Large-vessel arteritis associated with chronic active Epstein–Barr virus infection. Arthritis Rheum. 1998;41(2):369–73.CrossRef Murakami K, Ohsawa M, Hu SX, Kanno H, Aozasa K, Nose M. Large-vessel arteritis associated with chronic active Epstein–Barr virus infection. Arthritis Rheum. 1998;41(2):369–73.CrossRef
29.
go back to reference Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, et al. Epstein–Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 1988;333(6172):455–7.CrossRef Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, et al. Epstein–Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 1988;333(6172):455–7.CrossRef
30.
go back to reference Toubo T, Ohga S, Takada H, Suga N, Nomura A, Ohno T, Hara T. Rheumatic fever-mimicking carditis as a first presentation of chronic active Epstein–Barr virus infection. Acta Paediatr. 2006;95(5):614–8.CrossRef Toubo T, Ohga S, Takada H, Suga N, Nomura A, Ohno T, Hara T. Rheumatic fever-mimicking carditis as a first presentation of chronic active Epstein–Barr virus infection. Acta Paediatr. 2006;95(5):614–8.CrossRef
31.
go back to reference Kobayashi I, Hamada I, Tomizawa K, Kikuta H, Sakiyama Y, Matsumoto S. Chronic Epstein–Barr virus infections associated with coronary aneurysms. Acta Paediatr Jpn. 1989;31(4):509–12.CrossRef Kobayashi I, Hamada I, Tomizawa K, Kikuta H, Sakiyama Y, Matsumoto S. Chronic Epstein–Barr virus infections associated with coronary aneurysms. Acta Paediatr Jpn. 1989;31(4):509–12.CrossRef
32.
go back to reference Ohga S, Kimura N, Takada H, Nagano M, Ohshima K, Nomura A, Muraoka K, Take H, Yamamori S, Hara T. Restricted diversification of T-cells in chronic active Epstein–Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol. 1999;61(1):26–33.CrossRef Ohga S, Kimura N, Takada H, Nagano M, Ohshima K, Nomura A, Muraoka K, Take H, Yamamori S, Hara T. Restricted diversification of T-cells in chronic active Epstein–Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol. 1999;61(1):26–33.CrossRef
33.
go back to reference Nishimura S, Ehara S, Hanatani A, Yoshiyama M. Chronic active Epstein–Barr virus infection complicated with multiple artery aneurysms. Eur Heart J Cardiovasc Imaging. 2014;15(11):1255.CrossRef Nishimura S, Ehara S, Hanatani A, Yoshiyama M. Chronic active Epstein–Barr virus infection complicated with multiple artery aneurysms. Eur Heart J Cardiovasc Imaging. 2014;15(11):1255.CrossRef
34.
go back to reference Jiang S, Li X, Cao J, Wu D, Kong L, Lin L, Jin Z, An J, Wang Y. Early diagnosis and follow-up of chronic active Epstein–Barr-virus-associated cardiovascular complications with cardiovascular magnetic resonance imaging: A case report. Medicine (Baltimore). 2016;95(31):e4384.CrossRef Jiang S, Li X, Cao J, Wu D, Kong L, Lin L, Jin Z, An J, Wang Y. Early diagnosis and follow-up of chronic active Epstein–Barr-virus-associated cardiovascular complications with cardiovascular magnetic resonance imaging: A case report. Medicine (Baltimore). 2016;95(31):e4384.CrossRef
35.
go back to reference Xie XF, Huang P, Zhang L. A case of chronic active Epstein–Barr virus infection with concomitant giant coronary artery aneurysm. Zhonghua Er Ke Za Zhi. 2016;54(10):779–80.PubMed Xie XF, Huang P, Zhang L. A case of chronic active Epstein–Barr virus infection with concomitant giant coronary artery aneurysm. Zhonghua Er Ke Za Zhi. 2016;54(10):779–80.PubMed
36.
go back to reference Ba H, Xu L, Peng H, Lin Y, Li X, Wang H, Qin Y. Chronic active Epstein–Barr virus infection with systemic vasculitis and pulmonary arterial hypertension in a child. Front Pediatr. 2019;7:219.CrossRef Ba H, Xu L, Peng H, Lin Y, Li X, Wang H, Qin Y. Chronic active Epstein–Barr virus infection with systemic vasculitis and pulmonary arterial hypertension in a child. Front Pediatr. 2019;7:219.CrossRef
Metadata
Title
Chronic active Epstein–Barr virus infection manifesting as coronary artery aneurysm and uveitis
Authors
Haijuan Xiao
Bing Hu
Rongmu Luo
Huili Hu
Junmei Zhang
Weiying Kuang
Rui Zhang
Li Li
Gang Liu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2020
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01409-8

Other articles of this Issue 1/2020

Virology Journal 1/2020 Go to the issue